Danielle S Burstein1, Pirouz Shamszad2, Dingwei Dai2, Christopher S Almond3, Jack F Price4, Kimberly Y Lin2, Matthew J O'Connor2, Robert E Shaddy5, Christopher E Mascio2, Joseph W Rossano2. 1. Division of Pediatric Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA. Electronic address: bursteind@email.chop.edu. 2. Division of Pediatric Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA. 3. Division of Pediatric Cardiology, Stanford University, Palo Alto, CA. 4. Division of Pediatric Cardiology, Texas Children's Hospital, Houston, TX. 5. Department of Pediatrics, Children's Hospital of Los Angeles, Los Angeles, CA.
Abstract
BACKGROUND: Children with congenital heart disease (CHD) are at risk for advanced heart failure (AHF). We sought to define the mortality and resource utilization in CHD-related AHF in children and young adults. METHODS: All hospitalizations in the Pediatric Health Information System database involving patients ≤21 years old with a CHD diagnosis and heart failure requiring at least 7 days of continuous inotropic support between 2004 and 2015 were included. Hospitalizations including CHD surgery were excluded. RESULTS: Of 465,482 CHD hospitalizations, AHF was present in 2,712 (0.6%) [58% infant, 55% male, 30% single ventricle]. AHF therapies frequently used included extracorporeal membrane oxygenation (ECMO) (15%) and cardiac transplant (16%). Ventricular assist device (VAD) support was rare (3%), although VAD use significantly increased from 2004 to 2015 (P < .0010). Hospital mortality in CHD with AHF was 26%, with higher mortality associated with single ventricle heart disease (OR 1.64, 95% CI 1.23-2.19; P = .0009), infancy (OR 1.71, 95% CI 1.17-2.5; P = .0057), non-white race (OR 1.28, 95% CI 1.04-1.59; p=0.0234), and chronic complex comorbidities (OR 1.76, 95% CI 1.34-2.30; P < .0001). Over the 11-year study period, despite the significant increase in CHD-related AHF hospitalizations (P < .0001), hospital mortality improved (P = .0011). Median hospital costs were $252,000, a 6-fold increase above those without AHF, and was primarily driven by hospital length of stay (P < .0001). CONCLUSION: AHF in children with CHD in uncommon but increasing and is associated with significant morbidity, mortality and resource utilization. Approximately 1 in 5 children do not survive to hospital discharge. Many risk factors for mortality may not be modifiable, and further study is needed to identify modifiable risk factors and improve care for this complex population.
BACKGROUND:Children with congenital heart disease (CHD) are at risk for advanced heart failure (AHF). We sought to define the mortality and resource utilization in CHD-related AHF in children and young adults. METHODS: All hospitalizations in the Pediatric Health Information System database involving patients ≤21 years old with a CHD diagnosis and heart failure requiring at least 7 days of continuous inotropic support between 2004 and 2015 were included. Hospitalizations including CHD surgery were excluded. RESULTS: Of 465,482 CHD hospitalizations, AHF was present in 2,712 (0.6%) [58% infant, 55% male, 30% single ventricle]. AHF therapies frequently used included extracorporeal membrane oxygenation (ECMO) (15%) and cardiac transplant (16%). Ventricular assist device (VAD) support was rare (3%), although VAD use significantly increased from 2004 to 2015 (P < .0010). Hospital mortality in CHD with AHF was 26%, with higher mortality associated with single ventricle heart disease (OR 1.64, 95% CI 1.23-2.19; P = .0009), infancy (OR 1.71, 95% CI 1.17-2.5; P = .0057), non-white race (OR 1.28, 95% CI 1.04-1.59; p=0.0234), and chronic complex comorbidities (OR 1.76, 95% CI 1.34-2.30; P < .0001). Over the 11-year study period, despite the significant increase in CHD-related AHF hospitalizations (P < .0001), hospital mortality improved (P = .0011). Median hospital costs were $252,000, a 6-fold increase above those without AHF, and was primarily driven by hospital length of stay (P < .0001). CONCLUSION: AHF in children with CHD in uncommon but increasing and is associated with significant morbidity, mortality and resource utilization. Approximately 1 in 5 children do not survive to hospital discharge. Many risk factors for mortality may not be modifiable, and further study is needed to identify modifiable risk factors and improve care for this complex population.
Authors: Chris A Rees; Mark I Neuman; Michael C Monuteaux; Kenneth A Michelson; Christopher P Duggan Journal: J Pediatr Date: 2022-03-29 Impact factor: 6.314
Authors: Louis Ehwerhemuepha; Bradley Roth; Anita K Patel; Olivia Heutlinger; Carly Heffernan; Antonio C Arrieta; Terence Sanger; Dan M Cooper; Babak Shahbaba; Anthony C Chang; William Feaster; Sharief Taraman; Hiroki Morizono; Rachel Marano Journal: JAMA Netw Open Date: 2022-05-02
Authors: Indah K Murni; Muhammad Taufik Wirawan; Linda Patmasari; Esta R Sativa; Nadya Arafuri; Sasmito Nugroho Journal: BMC Pediatr Date: 2021-04-21 Impact factor: 2.125
Authors: Anitha S John; Jamie L Jackson; Philip Moons; Karen Uzark; Andrew S Mackie; Susan Timmins; Keila N Lopez; Adrienne H Kovacs; Michelle Gurvitz Journal: J Am Heart Assoc Date: 2022-03-17 Impact factor: 6.106
Authors: Justin H Berger; Jennifer A Faerber; Feiyan Chen; Kimberly Y Lin; Julie A Brothers; Michael L O'Byrne Journal: J Am Heart Assoc Date: 2022-03-18 Impact factor: 6.106